Patient-reported outcome measures in discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS): results of a multicenter randomized controlled trial

Authors
Category Primary study
ConferenceMultiple Sclerosis Journal
Year 2023
This article has no abstract
Epistemonikos ID: 0a02dbd098322d6571dd3ae902700d2fc0ce4ff5
First added on: Apr 30, 2026